| Literature DB >> 25433533 |
Pachaiyappan Saravana Kumar, Naif Abdullah Al-Dhabi, Veeramuthu Duraipandiyan, Chandrasekar Balachandran, Panthagani Praveen Kumar, Savarimuthu Ignacimuthu.
Abstract
BACKGROUND: Actinomycetes are Gram-positive, often filamentous, bacteria known for their unsurpassed capacity for the production of secondary metabolites with diverse biological activities. The aim of the present study was to evaluate the antimicrobial, cytotoxic and antioxidant properties of Streptomyces lavendulae strain SCA5.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25433533 PMCID: PMC4265329 DOI: 10.1186/s12866-014-0291-6
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Morphological features of strain SCA5 on different media
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| AIA | Grey | Grey | - | White | +++ |
| Agar | White | White | - | White | + |
| ISP 2 | White | White | - | Brownish yellow | +++ |
| MHA | - | Slimy yellow | - | Slimy yellow | + |
| SCA | Greyish White | Greyish white | - | Yellow | +++ |
| SDA | - | Yellow | - | Yellow | ++ |
| SKM | Yellowish white | Yellowish white | - | Yellow | ++ |
| STP | Dark grey | Dark grey | - | Yellowish grey | +++ |
| YPG | Whitish yellow | Yellow | - | Yellow | +++ |
| ZMA | - | Slimy Yellow | - | Whitish yellow | + |
+++ Good growth; ++ Moderate growth; + Weak growth: − absent.
Physiological and biochemical characteristics of strain SCA5
|
|
|
|---|---|
| Gram staining | Positive |
| Shape and growth | filamentous aerial growth |
| Range of temperature for growth | 25°C to 37°C |
| Optimum temperature | 30°C |
| Range of pH for growth | 3 to 11 |
| Optimum pH | 7 |
| Growth in the presence of NaCl | 1 to 9% |
| Amylase | +++ |
| Chitinase | + |
| Protease | ++ |
| Gelatinase | +++ |
| Lipase | ++ |
+++ Good activity; ++ Moderate activity; + Weak activity.
Figure 1Antimicrobial activity of EA-SCA5 using disc diffusion method.
Antimicrobial activity of strain SCA5 ethyl acetate extract using disc diffusion method
|
| ||
|---|---|---|
|
| ||
|
|
| |
|
| 12 | 20 |
|
| 10 | 10 |
|
| 10 | 12 |
|
| 13 | 15 |
|
| 11 | 16 |
|
| 11 | 35 |
|
| 10 | 24 |
|
| 12 | 19 |
|
| 13 | 13 |
|
| 10 | 12 |
|
|
| |
|
| 13 | 27 |
|
| 15 | 30 |
|
| 11 | 23 |
|
| 13 | 25 |
| MRSA | 12 | 24 |
|
| ||
|
| 11 | 28 |
|
| 10 | 24 |
|
| 10 | 18 |
|
| 10 | 20 |
|
| 14 | 21 |
|
| 15 | 29 |
|
| 10 | 18 |
|
| 13 | 11 |
EA-SCA5: Ethyl acetate extract, Ketoconazole: Antifungal Agent.
Streptomycin: Antibacterial agent.
Minimum inhibitory concentration of the strain SCA5 ethyl acetate extract
|
|
| |
|---|---|---|
|
| >31.25 μg/ml | >12.5 μg/ml |
|
| >1000 μg/ml | >12.5 μg/ml |
|
| >1000 μg/ml | >6.25 μg/ml |
|
| >1000 μg/ml | >6.25 μg/ml |
|
| >500 μg/ml | >12.5 μg/ml |
|
| >500 μg/ml | >12.5 μg/ml |
|
| >250 μg/ml | >25 μg/ml |
|
| >1000 μg/ml | >12.5 μg/ml |
|
| >250 μg/ml | >12.5 μg/ml |
|
| >1000 μg/ml | >12.5 μg/ml |
|
|
| |
|
| >500 μg/ml | >6.25 μg/ml |
|
| >125 μg/ml | >6.25 μg/ml |
|
| >500 μg/ml | >6.25 μg/ml |
|
| >500 μg/ml | >6.25 μg/ml |
| MRSA | >250 μg/ml | >25 μg/ml |
|
| ||
|
| >500 μg/ml | |
|
| >1000 μg/ml | >25 μg/ml |
|
| >1000 μg/ml | >25 μg/ml |
|
| >1000 μg/ml | >6.25 μg/ml |
|
| >250 μg/ml | >30 μg/ml |
|
| >125 μg/ml | >30 μg/ml |
|
| >1000 μg/ml | >6.25 μg/ml |
|
| >250 μg/ml | >6.25 μg/ml |
Ketoconazole: Antifungal Agent.
Streptomycin: Antibacterial agent.
Figure 2Antioxidant activity. a. DPPH radical scavenging activity of different concentrations (200–1000 μg/ml) of EA-SCA5 and Vitamin C. Each value presents the mean ± SEM of triplicate experiments. b. Hydroxyl radical scavenging activity of different concentrations (200–1000 μg/ml) of EA-SCA5 and Vitamin C. Each value presents the mean ± SEM of triplicate experiments. c. Nitric oxide radical scavenging activity of different concentrations (200–1000 μg/ml) of EA-SCA5 and Vitamin C. Each value presents the mean ± SEM of triplicate experiments. d. Superoxide anion radical-scavenging activity of different concentrations (200–1000 μg/ml) of EA-SCA5 and Vitamin C. Each value presents the mean ± SEM of triplicate experiments. e. Lipid peroxidation inhibition of different concentrations (200–1000 μg/ml) of EA-SCA5 and Vitamin C. Each value presents the mean ± SEM of triplicate experiments. f. Reducing power determination of different concentrations (200–1000 μg/ml) of EA-SCA5 and BHT. Each value presents the mean ± SEM of triplicate experiments.
Figure 3Cytotoxic effects of EA-SCA5 on cancer cell line (A549). Data are mean ± SD of three independent experiments with each experiment conducted in triplicate.
Figure 4TLC profile of the active crude from soil strain SCA5. a. Viewed under normal white light. b. Viewed under UV 366 nm. c. Derivatization with 10% alcoholic sulphuric acid. d. Exposure to iodine vapour. e. 0.01% ferric chloride. f. 0.01% alcoholic NaOH.
GC-MS profile of the strain SCA5 ethyl acetate extract
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| 1. | 4.68 | Octaethylene glycol monododecyl ether | C28H58O9 | 538 | 0.48 |
| 2. | 4.75 | 2(3H)Furanone,5acetyldihydro | C6H8O3 | 128 | 2.62 |
| 3. | 5.37 | 1,4Dioxane2,5dione,3,6dimethyl | C6H8O4 | 144 | 2.24 |
| 4. | 10.31 | Hexanoic acid, 2phenylethyl ester | C14H20O2 | 220 | 0.59 |
| 5. | 11.77 | 2,4Dimethyl3pentanol acetate | C9H18O2 | 158 | 1.06 |
| 6. | 11.96 | Hexadecanoic acid, 1(hydroxymethyl)1,2ethanediyl ester | C35H68O5 | 568 | 0.86 |
| 7. | 14.31,16.27,17.28,17.68, 27.47 | Actinomycin C2 | C63H88N12O16 | 1268 | 7.12 |
| 8. | 17.55, 18.00 | Hexadecanoic acid | C16H32O2 | 256 | 14.75 |
| 9. | 20.39 | Oleic Acid | C18H34O2 | 282 | 26.46 |
| 10. | 20.77 | 2,5Piperazinedione,3,6bis(2methylpropyl) | C12H22N2O2 | 226 | 8.42 |
| 11. | 22.75,23.27 | Ergotaman | C33H35N5O5 | 581 | 3.56 |
Figure 5GC-MS analysis of active crude from soil strain SCA5.